New research on low-dose aspirin published
An article in the current issue of JAMA reports on the efficacy of low-dose aspirin for the primary prevention of atherosclerotic events in patients with type 2 diabetes.
This was a multicenter, prospective, randomized, open-label, blinded, end-point trial conducted from December 2002 through April 2008 at 163 institutions throughout Japan, involving 2539 patients with type 2 [...]